Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Phase II Trial of Short-course Radiotherapy Based Total Neoadjuvant Therapy Combined With PD-1 Inhibitor for Locally Advanced Rectal Cancer (TORCH）

NCT04518280 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT04518280
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04518280 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Phase II Trial of Short-course Radiotherapy Based Total Neoadjuvant Therapy Combined With PD-1 Inhibitor for Locally Advanced Rectal Cancer (TORCH）
Lead sponsor
Fudan University
Phase
Phase 2
Overall status
Completed
Start date
May 1, 2021
Completion date
January 1, 2025
Enrollment
130 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced rectal cancer